Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia

NCT00005829 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: gemcitabine hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]